FDA Says Ivermectin Remains Unapproved for COVID-19 Treatment

An ivermectin bottle next to a positive blood sample of COVID-19. Novikov Aleksey/Shutterstock

The U.S. Food and Drug Administration (FDA) on Aug. 17 clarified that it had not authorized or approved the use of ivermectin in preventing or treating COVID-19.

Ivermectin is an FDA-approved antiparasitic drug that is used to treat neglected tropical diseases, including parasitic worm infections (helminthiases), onchocerciasis (or river blindness), and scabies.